CLINICAL_TRIALS
trial_result
· 2016-06-30
Clinical Trial Update: Valganciclovir Dosing in Pediatric Solid Organ Transplant Recipients [Phase 4]
Summary
Phase 4 study evaluated valganciclovir dosing in pediatric solid organ transplant recipients to prevent CMV infection; results were posted in 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Rabin Medical Center | Conditions: Infection in Solid Organ Transplant Recipients | Phase 4 | Status: COMPLETED | Results posted: 2016-06-30